National Association of Chain Drug Stores
FDANonrulemakingFDA-2022-N-0165

Providing Mail-Back Envelopes and Education on Safe Disposal With Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments

RIN
Last modified
Jun 30, 2022
Comment window
closed 1498d ago
National Association of Chain Drug Stores filings
1

Activity

National Association of Chain Drug Stores filed 1 comment on this docket between Jun 22, 2022 and Jun 22, 2022. 23 other organizations filed here. The comment window closed 1498d ago.

What National Association of Chain Drug Stores filed (1)

Jun 22, 2022· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2022-N-0165-0174

Please see the attached comments of the National Association of Chain Drug Stores regarding the potential modification to the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS) to require the provision of mail-back envelopes and education on safe disposal for opioid prescriptions dispensed in outpatient settings (FDA–2022–N–0165).

Abstract

No abstract recorded.

View on regulations.gov →
Providing Mail-Back Envelopes and Education on Safe Disposal With Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments (FDA) — National Association of Chain Drug Stores | OpenPolis